Fortis Healthcare secures approval for debenture modifications

Fortis Healthcare Limited announced on December 19, 2025, that it received final approval from BSE Limited for modifications and alterations to the terms of its debentures. This approval was granted at 16:43 Hours (IST), following a previous intimation issued on December 4, 2025. The company stated that this development is for the information and records of its stakeholders.

The announcement was made in compliance with Regulation 30 and 51 of the SEBI (Listing Obligations & Disclosure Requirements) Regulations 2015. Satyendra Chauhan, company secretary and compliance officer of Fortis Healthcare Limited, signed the disclosure.